Astrazeneca (AZN) Finished Goods (2015 - 2025)
Astrazeneca (AZN) posted quarterly Finished Goods of $1.9 billion for Q4 2025, up 26.76% year-over-year from $1.5 billion in Q4 2024, and up 26.76% quarter-over-quarter from $1.5 billion in Q4 2024.
Astrazeneca (AZN) Finished Goods (2015 - 2025) Analysis & Trends
Astrazeneca's Finished Goods history runs 11 years deep, the most recent figure standing at $1.9 billion for Q4 2025.
- In Q4 2025, Finished Goods rose 26.76% year-over-year to $1.9 billion; the TTM figure through Dec 2025 stood at $1.9 billion (up 26.76% YoY), while the FY2025 annual figure was $1.9 billion, up 26.76% from the prior year.
- Finished Goods for Q4 2025 stood at $1.9 billion, up from $1.5 billion in the prior quarter.
- The five-year high for Finished Goods was $2.0 billion in Q4 2021, with the low at $1.4 billion in Q4 2022.
- The 5-year median for Finished Goods is $1.6 billion (2023), against an average of $1.7 billion.
- The sharpest annual moves came in 2021 and 2022: Finished Goods jumped 40.6% in 2021, then dropped 29.77% in 2022.
- Astrazeneca's Finished Goods stood at $2.0 billion in 2021, then slipped by 29.77% to $1.4 billion in 2022, then climbed by 10.97% to $1.6 billion in 2023, then decreased by 3.25% to $1.5 billion in 2024, then increased by 26.76% to $1.9 billion in 2025.
- Business Quant data shows AZN's Finished Goods at $1.9 billion in Q4 2025, $1.5 billion in Q4 2024, and $1.6 billion in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.92 Bn |
| Dec 31, 2024 | 1.52 Bn |
| Dec 31, 2023 | 1.57 Bn |
| Dec 31, 2022 | 1.41 Bn |
| Dec 31, 2021 | 2.01 Bn |
| Dec 31, 2020 | 1.43 Bn |
| Dec 31, 2019 | 1.09 Bn |
| Dec 31, 2018 | 646.00 Mn |
| Dec 31, 2017 | 803.00 Mn |
| Dec 31, 2016 | 463.00 Mn |
| Dec 31, 2015 | 638.00 Mn |